Is polypharmacy an increasing burden in chronic kidney disease? The German experience

This is a commentary article describing the key findings of the German chronic kidney disease (GCKD) study and how these relate to current practice. With the GCKD study showing high levels of polypharmacy, this article discusses ways to ensure that polypharmacy is appropriate and the difficulties fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Kathrine, Wong, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
CKD
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768297/
https://www.ncbi.nlm.nih.gov/pubmed/31584570
http://dx.doi.org/10.1093/ckj/sfz072
_version_ 1783455078815891456
author Parker, Kathrine
Wong, Joanne
author_facet Parker, Kathrine
Wong, Joanne
author_sort Parker, Kathrine
collection PubMed
description This is a commentary article describing the key findings of the German chronic kidney disease (GCKD) study and how these relate to current practice. With the GCKD study showing high levels of polypharmacy, this article discusses ways to ensure that polypharmacy is appropriate and the difficulties faced within a chronic kidney disease population. Suggestions of ways to minimize medication burden in renal patients provide some practical advice for clinicians.
format Online
Article
Text
id pubmed-6768297
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-67682972019-10-03 Is polypharmacy an increasing burden in chronic kidney disease? The German experience Parker, Kathrine Wong, Joanne Clin Kidney J CKD This is a commentary article describing the key findings of the German chronic kidney disease (GCKD) study and how these relate to current practice. With the GCKD study showing high levels of polypharmacy, this article discusses ways to ensure that polypharmacy is appropriate and the difficulties faced within a chronic kidney disease population. Suggestions of ways to minimize medication burden in renal patients provide some practical advice for clinicians. Oxford University Press 2019-06-17 /pmc/articles/PMC6768297/ /pubmed/31584570 http://dx.doi.org/10.1093/ckj/sfz072 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle CKD
Parker, Kathrine
Wong, Joanne
Is polypharmacy an increasing burden in chronic kidney disease? The German experience
title Is polypharmacy an increasing burden in chronic kidney disease? The German experience
title_full Is polypharmacy an increasing burden in chronic kidney disease? The German experience
title_fullStr Is polypharmacy an increasing burden in chronic kidney disease? The German experience
title_full_unstemmed Is polypharmacy an increasing burden in chronic kidney disease? The German experience
title_short Is polypharmacy an increasing burden in chronic kidney disease? The German experience
title_sort is polypharmacy an increasing burden in chronic kidney disease? the german experience
topic CKD
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768297/
https://www.ncbi.nlm.nih.gov/pubmed/31584570
http://dx.doi.org/10.1093/ckj/sfz072
work_keys_str_mv AT parkerkathrine ispolypharmacyanincreasingburdeninchronickidneydiseasethegermanexperience
AT wongjoanne ispolypharmacyanincreasingburdeninchronickidneydiseasethegermanexperience

Ejemplares similares